Secondary prevention with verapamil after myocardial infarction
- 18 December 1990
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 66 (21), 33-40
- https://doi.org/10.1016/0002-9149(90)91262-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Effect of verapamil on postischemic “stunned” myocardium: Importance of the timing of treatmentJournal of the American College of Cardiology, 1988
- Calcium antagonists and the ischemic myocardiumInternational Journal of Cardiology, 1987
- Effects of calcium antagonists on infarcting myocardiumThe American Journal of Cardiology, 1987
- Letter to the EditorEuropean Heart Journal, 1986
- The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.British Journal of Clinical Pharmacology, 1986
- Verapamil in acute myocardial infarctionThe American Journal of Cardiology, 1984
- Verapamil in acute myocardial infarctionEuropean Heart Journal, 1984
- Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: Verapamil infusion in dogs with small myocardial infarctsThe American Journal of Cardiology, 1983
- Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testingThe American Journal of Cardiology, 1981